{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T06:27:30Z","timestamp":1794551250903,"version":"4.9.1"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.wneu.2026.125172","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:49:02Z","timestamp":1783007342000},"page":"125172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Global Trends and Evolving Frontiers in Intranasal Delivery for CNS Diseases (2000\u20132025): A Bibliometric Analysis and Systematic Review"],"prefix":"10.1016","volume":"212","author":[{"given":"Yi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2681-1613","authenticated-orcid":false,"given":"Jun","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jifang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2026.125172_bib1","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.euroneuro.2011.07.018","article-title":"The size and burden of mental disorders and other disorders of the brain in Europe 2010","volume":"21","author":"Wittchen","year":"2011","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.wneu.2026.125172_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood-brain barrier: structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.wneu.2026.125172_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","article-title":"Mechanism of intranasal drug delivery directly to the brain","volume":"195","author":"Crowe","year":"2018","journal-title":"Life Sci"},{"key":"10.1016\/j.wneu.2026.125172_bib4","article-title":"The nasal-brain drug delivery route: mechanisms and applications to central nervous system diseases","volume":"6","author":"Qiu","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.wneu.2026.125172_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.brainresbull.2018.10.009","article-title":"Evaluation of intranasal delivery route of drug administration for brain targeting","volume":"143","author":"Erd\u0151","year":"2018","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.wneu.2026.125172_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125584","article-title":"The review of nasal drug delivery system: the strategies to enhance the efficiency of intranasal drug delivery by improving drug absorption","volume":"676","author":"Wei","year":"2025","journal-title":"Int J Pharm"},{"key":"10.1016\/j.wneu.2026.125172_bib7","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2147\/IJN.S439181","article-title":"Recent advances in intranasal administration for brain-targeting delivery: a comprehensive review of lipid-based nanoparticles and stimuli-responsive gel formulations","volume":"19","author":"Koo","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.wneu.2026.125172_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-024-02107-5","article-title":"Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines","volume":"10","author":"Xiao","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.wneu.2026.125172_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae275","article-title":"Peptide-based drug discovery through artificial intelligence: towards an autonomous design of therapeutic peptides","volume":"25","author":"Goles","year":"2024","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.wneu.2026.125172_bib10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00401-025-02902-6","article-title":"The olfactory epithelium: a critical gateway for pathological tau propagation and a target for mitigating tauopathy in the central nervous system","volume":"149","author":"Dourte","year":"2025","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.wneu.2026.125172_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.wneu.2026.125172_bib12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2174\/156720507780362137","article-title":"Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment","volume":"4","author":"Craft","year":"2007","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.wneu.2026.125172_bib13","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI57256","article-title":"An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease-associated A\u03b2 oligomers","volume":"122","author":"Bomfim","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.wneu.2026.125172_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/brain\/awac309","article-title":"Cerebrovascular insulin receptors are defective in Alzheimer's disease","volume":"146","author":"Leclerc","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.wneu.2026.125172_bib15","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1038\/srep03754","article-title":"Reduced phosphorylation of brain insulin receptor substrate and Akt proteins in apolipoprotein-E4 targeted replacement mice","volume":"4","author":"Ong","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.wneu.2026.125172_bib16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuron.2017.09.003","article-title":"Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes","volume":"96","author":"Zhao","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.wneu.2026.125172_bib17","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s13098-025-01930-2","article-title":"A systematic review on type 3 diabetes: bridging the gap between metabolic dysfunction and Alzheimer's disease","volume":"17","author":"Atabi","year":"2025","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.wneu.2026.125172_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252211955","article-title":"Alzheimer's disease as type 3 diabetes: understanding the link and implications","volume":"25","author":"Kciuk","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.wneu.2026.125172_bib19","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","article-title":"Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches","volume":"19","author":"Kellar","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.wneu.2026.125172_bib20","doi-asserted-by":"crossref","first-page":"E156","DOI":"10.1152\/ajpendo.00642.2020","article-title":"Insulin action in the brain regulates both central and peripheral functions","volume":"321","author":"Agrawal","year":"2021","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.wneu.2026.125172_bib21","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.3390\/pharmaceutics13111745","article-title":"Investigation of the transport pathways associated with enhanced brain delivery of peptide drugs by intranasal coadministration with penetratin","volume":"13","author":"Kamei","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.wneu.2026.125172_bib22","article-title":"First-in-human positron emission tomography study of intranasal insulin in aging and MCI","volume":"11","author":"Sai","year":"2025","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.wneu.2026.125172_bib23","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nn0602-849","article-title":"Sniffing neuropeptides: a transnasal approach to the human brain","volume":"5","author":"Born","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.wneu.2026.125172_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/dom.14213","article-title":"Intranasal insulin administration decreases cerebral blood flow in cortico-limbic regions: a neuropharmacological imaging study in normal and overweight males","volume":"23","author":"Wingrove","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.wneu.2026.125172_bib25","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.2337\/db12-0025","article-title":"Intranasal insulin suppresses food intake via enhancement of brain energy levels in humans","volume":"61","author":"Jauch-Chara","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.wneu.2026.125172_bib26","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1210\/jc.2007-2606","article-title":"Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin","volume":"93","author":"Benedict","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2026.125172_bib27","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1212\/01.WNL.0000265401.62434.36","article-title":"Intranasal insulin improves cognition and modulates beta-amyloid in early AD","volume":"70","author":"Reger","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2026.125172_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial","volume":"69","author":"Craft","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.wneu.2026.125172_bib29","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3233\/JAD-141791","article-title":"Long acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer\u2019s Disease dementia","volume":"44","author":"Claxton","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.wneu.2026.125172_bib30","doi-asserted-by":"crossref","first-page":"240","DOI":"10.14283\/jpad.2021.14","article-title":"Intranasal insulin reduces white matter hyperintensity progression in association with improvements in cognition and CSF biomarker profiles in mild cognitive impairment and Alzheimer's disease","volume":"8","author":"Kellar","year":"2021","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.wneu.2026.125172_bib31","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/s41598-022-05165-3","article-title":"Intranasal insulin modulates cerebrospinal fluid markers of neuroinflammation in mild cognitive impairment and Alzheimer's disease: a randomized trial","volume":"12","author":"Kellar","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.wneu.2026.125172_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70704","article-title":"A phase 2A\/B randomized trial of metabolic modulators intranasal insulin and empagliflozin for MCI and early AD","volume":"21","author":"Erichsen","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.wneu.2026.125172_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2025.102559","article-title":"Therapeutic potential of small peptides in Alzheimer's disease: advances in memory restoration and targeted delivery systems","volume":"114","author":"Verma","year":"2025","journal-title":"Neuropeptides"},{"key":"10.1016\/j.wneu.2026.125172_bib34","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41398-024-03118-0","article-title":"Davunetide sex-dependently boosts memory in prodromal Alzheimer's disease","volume":"14","author":"Gozes","year":"2024","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.wneu.2026.125172_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.125055","article-title":"Peptide-based inhibitors and nanoparticles: emerging therapeutics for Alzheimer's disease","volume":"669","author":"Mojarad-Jabali","year":"2025","journal-title":"Int J Pharm"},{"key":"10.1016\/j.wneu.2026.125172_bib36","first-page":"301","article-title":"Social effects of oxytocin in humans: context and person matter","volume":"15","author":"Bartz","year":"2011","journal-title":"Trends Cogn Sci"},{"key":"10.1016\/j.wneu.2026.125172_bib37","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1152\/physrev.00031.2017","article-title":"The oxytocin receptor: from intracellular signaling to behavior","volume":"98","author":"Jurek","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/j.wneu.2026.125172_bib38","first-page":"180","article-title":"Oxytocin determination by radioimmunoassay","volume":"16","author":"Vankrieken","year":"1983","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.wneu.2026.125172_bib39","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1054-3589(04)50014-5","article-title":"Brain-fluid barriers: relevance for theoretical controversies regarding vasopressin and oxytocin memory research","volume":"50","author":"McEwen","year":"2004","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.wneu.2026.125172_bib40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neubiorev.2020.12.028","article-title":"Intranasal oxytocin in the treatment of autism spectrum disorders: a multilevel meta-analysis","volume":"122","author":"Huang","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.wneu.2026.125172_bib41","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13229-020-0313-1","article-title":"Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up","volume":"11","author":"Bernaerts","year":"2020","journal-title":"Mol Autism"},{"key":"10.1016\/j.wneu.2026.125172_bib42","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1056\/NEJMoa2103583","article-title":"Intranasal oxytocin in children and adolescents with autism spectrum disorder","volume":"385","author":"Sikich","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.wneu.2026.125172_bib43","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJMe2110158","article-title":"Oxytocin for autism spectrum disorder - down, but not out","volume":"385","author":"Geschwind","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.wneu.2026.125172_bib44","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000534114","article-title":"At the head and heart of oxytocin's stress-regulatory neural and cardiac effects: a chronic administration RCT in children with autism","volume":"92","author":"Alaerts","year":"2023","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.wneu.2026.125172_bib45","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000524543","article-title":"Infrequent intranasal oxytocin followed by positive social interaction improves symptoms in autistic children: a pilot randomized clinical trial","volume":"91","author":"Le","year":"2022","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.wneu.2026.125172_bib46","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13229-023-00546-5","article-title":"Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial","volume":"14","author":"Daniels","year":"2023","journal-title":"Mol Autism"},{"key":"10.1016\/j.wneu.2026.125172_bib47","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41467-023-44334-4","article-title":"Chronic oxytocin administration stimulates the oxytocinergic system in children with autism","volume":"15","author":"Moerkerke","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.wneu.2026.125172_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9758\/cpn.2019.17.1.1","article-title":"The role of intranasal oxytocin in anxiety and depressive disorders: a systematic review of randomized controlled trials","volume":"17","author":"De Cagna","year":"2019","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"10.1016\/j.wneu.2026.125172_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2025.107530","article-title":"Boosting oxytocin in postpartum depression: intranasal oxytocin enhances maternal positive affect and regard for the infant","volume":"179","author":"Riem","year":"2025","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.wneu.2026.125172_bib50","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3389\/fpsyg.2015.00426","article-title":"Intranasal adminsitration of oxytocin in postnatal depression: implications for psychodynamic psychotherapy from a randomized double-blind pilot study","volume":"6","author":"Clarici","year":"2015","journal-title":"Front Psychol"},{"key":"10.1016\/j.wneu.2026.125172_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110098","article-title":"Oxytocin effects on the cognition of women with postpartum depression: a randomized, placebo-controlled clinical trial","volume":"111","author":"Donadon","year":"2021","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.wneu.2026.125172_bib52","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.pnpbp.2012.10.005","article-title":"Oxytocin in postnatally depressed mothers: its influence on mood and expressed emotion","volume":"40","author":"Mah","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.wneu.2026.125172_bib53","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/da.22245","article-title":"Oxytocin promotes protective behavior in depressed mothers: a pilot study with the enthusiastic stranger paradigm","volume":"32","author":"Mah","year":"2015","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.wneu.2026.125172_bib54","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s10578-016-0642-7","article-title":"The effects of intranasal oxytocin administration on sensitive caregiving in mothers with postnatal depression","volume":"48","author":"Mah","year":"2017","journal-title":"Child Psychiatry Hum Dev"},{"key":"10.1016\/j.wneu.2026.125172_bib55","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jad.2021.11.062","article-title":"Intranasal oxytocin administration improves mood in new mothers with moderate low mood but not in mothers with elevated symptoms of postnatal depression: a randomised controlled trial","volume":"300","author":"Lindley Baron-Cohen","year":"2022","journal-title":"J Affect Disord"},{"key":"10.1016\/j.wneu.2026.125172_bib56","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1017\/S0954579424001585","article-title":"Maternal mind-mindedness and infant oxytocin are interrelated and negatively associated with postnatal depression","volume":"37","author":"Lindley Baron-Cohen","year":"2025","journal-title":"Dev Psychopathol"},{"key":"10.1016\/j.wneu.2026.125172_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.116269","article-title":"Sex differences in response to intranasal oxytocin as an adjunctive therapy for patients with severe mental illness","volume":"342","author":"Maoz","year":"2024","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.wneu.2026.125172_bib58","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jad.2023.11.053","article-title":"Intranasal oxytocin as an adjunct treatment among patients with severe major depression with and without comorbid borderline personality disorder","volume":"347","author":"Maoz","year":"2024","journal-title":"J Affect Disord"},{"key":"10.1016\/j.wneu.2026.125172_bib59","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1474-4422(24)00456-3","article-title":"Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a\/2b superiority trial","volume":"24","author":"Coleman","year":"2025","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.wneu.2026.125172_bib60","article-title":"Intranasal oxytocin and physical intimacy for dermatological wound healing and neuroendocrine stress: a randomized clinical trial","volume":"83","author":"Schneider","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.wneu.2026.125172_bib61","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13023-025-03560-3","article-title":"Early oxytocin treatment in infants with Prader-Willi syndrome is safe and is associated with better endocrine, metabolic and behavioral outcomes","volume":"20","author":"Valette","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.wneu.2026.125172_bib62","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ijgo.13441","article-title":"Intranasal oxytocin as a treatment for chronic pelvic pain: a randomized controlled feasibility study","volume":"152","author":"Flynn","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.wneu.2026.125172_bib63","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13550-025-01329-0","article-title":"First-in-human intranasal [13N]oxytocin PET: evaluation of feasibility, biodistribution, and radiation dosimetry","volume":"15","author":"Winterdahl","year":"2025","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.wneu.2026.125172_bib64","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.bja.2024.12.046","article-title":"Plasma pharmacokinetics of intravenous and intranasal oxytocin in nonpregnant adults","volume":"134","author":"Shafer","year":"2025","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.wneu.2026.125172_bib65","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1126\/science.7201163","article-title":"Oxytocin, vasopressin, and estrogen-stimulated neurophysin: daily patterns of concentration in cerebrospinal fluid","volume":"216","author":"Perlow","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.wneu.2026.125172_bib66","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1210\/jcem-57-5-947","article-title":"A time-dependent peak of oxytocin exists in cerebrospinal fluid but not in plasma of humans","volume":"57","author":"Amico","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2026.125172_bib67","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1210\/jcem-61-4-794","article-title":"Neurohypophysial hormones in cerebrospinal fluid of adults: absence of arginine vasotocin and of a diurnal rhythm of arginine vasopressin","volume":"61","author":"Amico","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2026.125172_bib68","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1210\/endrev\/bnaf008","article-title":"The oxytocin system and implications for oxytocin deficiency in hypothalamic-pituitary disease","volume":"46","author":"Aulinas","year":"2025","journal-title":"Endocr Rev"},{"key":"10.1016\/j.wneu.2026.125172_bib69","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3390\/pharmaceutics17111447","article-title":"Nanoparticle-mediated nose-to-brain delivery for ischemic stroke therapy: preclinical insights","volume":"17","author":"Park","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.wneu.2026.125172_bib70","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00401-018-1930-z","article-title":"Post-stroke inflammation-target or tool for therapy?","volume":"137","author":"Lambertsen","year":"2019","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.wneu.2026.125172_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000330","article-title":"The interleukin-4\/PPAR\u03b3 signaling axis promotes oligodendrocyte differentiation and remyelination after brain injury","volume":"17","author":"Zhang","year":"2019","journal-title":"PLoS Biol"},{"key":"10.1016\/j.wneu.2026.125172_bib72","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12974-022-02471-5","article-title":"Interleukin 13 promotes long-term recovery after ischemic stroke by inhibiting the activation of STAT3","volume":"19","author":"Chen","year":"2022","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.wneu.2026.125172_bib73","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12974-024-03264-8","article-title":"IL-33\/ST2 signaling in monocyte-derived macrophages maintains blood-brain barrier integrity and restricts infarctions early after ischemic stroke","volume":"21","author":"Wang","year":"2024","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.wneu.2026.125172_bib74","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.2147\/JIR.S448903","article-title":"Piezo1 knockout improves post-stroke cognitive dysfunction by inhibiting the Interleukin-6 (IL-6)\/Glutathione peroxidase 4 (GPX4) pathway","volume":"17","author":"Tang","year":"2024","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.wneu.2026.125172_bib75","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.WCB.0000046146.31247.A1","article-title":"Neuroprotection by complement (C1) inhibitor in mouse transient brain ischemia","volume":"23","author":"De Simoni","year":"2003","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.wneu.2026.125172_bib76","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/01.RES.0000232544.90675.42","article-title":"Complement component C3 mediates inflammatory injury following focal cerebral ischemia","volume":"99","author":"Mocco","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.wneu.2026.125172_bib77","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/jcbfm.2015.41","article-title":"Mild hypothermia inhibits systemic and cerebral complement activation in a swine model of cardiac arrest","volume":"35","author":"Gong","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.wneu.2026.125172_bib78","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/sj.emboj.7601004","article-title":"Complement: a novel factor in basal and ischemia-induced neurogenesis","volume":"25","author":"Rahpeymai","year":"2006","journal-title":"EMBO J"},{"key":"10.1016\/j.wneu.2026.125172_bib79","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1002\/stem.225","article-title":"Complement-derived anaphylatoxin C3a regulates in vitro differentiation and migration of neural progenitor cells","volume":"27","author":"Shinjyo","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.wneu.2026.125172_bib80","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/brain\/aww314","article-title":"Complement peptide C3a stimulates neural plasticity after experimental brain ischaemia","volume":"140","author":"Stokowska","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.wneu.2026.125172_bib81","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162253","article-title":"Complement C3a treatment accelerates recovery after stroke via modulation of astrocyte reactivity and cortical connectivity","volume":"133","author":"Stokowska","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.wneu.2026.125172_bib82","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ymthe.2024.01.004","article-title":"Targeting SRSF3 restores immune mRNA translation in microglia\/macrophages following cerebral ischemia","volume":"32","author":"Rahimian","year":"2024","journal-title":"Mol Ther"},{"key":"10.1016\/j.wneu.2026.125172_bib83","article-title":"Intranasal delivery of extracellular vesicles derived from human bone marrow mesenchymal stem cells dampens neuroinflammation and ameliorates motor deficits in a mouse model of cortical stroke","volume":"396","author":"Barbati","year":"2025","journal-title":"Exp Neurol"},{"key":"10.1016\/j.wneu.2026.125172_bib84","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1186\/s12951-025-03652-z","article-title":"hUMSC-Exosomes suppress TREM1-p38 MAPK signaling via HMGB1-dependent mechanisms to reprogram microglial function and promote neuroprotection in ischemic stroke","volume":"23","author":"Zhang","year":"2025","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.wneu.2026.125172_bib85","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1007\/s13311-021-01076-9","article-title":"Mesenchymal stem cell (MSC)-derived extracellular vesicles protect from neonatal stroke by interacting with microglial cells","volume":"18","author":"Pathipati","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.wneu.2026.125172_bib86","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12974-024-03105-8","article-title":"Mas receptor activation facilitates innate hematoma resolution and neurological recovery after hemorrhagic stroke in mice","volume":"21","author":"Deng","year":"2024","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.wneu.2026.125172_bib87","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/STROKEAHA.123.043005","article-title":"Fractalkine enhances hematoma resolution and improves neurological function via CX3CR1\/AMPK\/PPAR\u03b3 pathway after GMH","volume":"54","author":"Chen","year":"2023","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2026.125172_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202400304","article-title":"Intranasal delivery of curcumin nanoparticles improves neuroinflammation and neurological deficits in mice with intracerebral hemorrhage","volume":"8","author":"Duan","year":"2024","journal-title":"Small Methods"},{"key":"10.1016\/j.wneu.2026.125172_bib89","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ame2.12179","article-title":"Animal models of stroke","volume":"4","author":"Li","year":"2021","journal-title":"Animal Model Exp Med"},{"key":"10.1016\/j.wneu.2026.125172_bib90","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/ame2.12166","article-title":"Preclinical animal studies in ischemic stroke: challenges and some solutions","volume":"4","author":"Narayan","year":"2021","journal-title":"Animal Model Exp Med"},{"key":"10.1016\/j.wneu.2026.125172_bib91","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1158\/1078-0432.CCR-03-0807","article-title":"Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients","volume":"10","author":"Ostermann","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.wneu.2026.125172_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2025.114898","article-title":"Intranasal delivery of temozolomide and disulfiram in situ gel combined with copper for enhanced glioblastoma therapy","volume":"255","author":"Qu","year":"2025","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.wneu.2026.125172_bib93","article-title":"Temozolomide hexadecyl ester targeted plga nanoparticles for drug-resistant glioblastoma therapy via intranasal administration","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.wneu.2026.125172_bib94","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s13346-025-01895-9","article-title":"Intranasal administration of temozolomide conjugated nanoparticles with transcranial magnetic stimulation improves the survival in glioblastoma xenograft models","volume":"16","author":"Koh","year":"2026","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.wneu.2026.125172_bib95","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.xphs.2024.11.030","article-title":"Targeted thermosensitive liposomes loaded with gold nanoparticles and temozolomide hexadecanoate for the synergistic photothermal-chemotherapy treatment of glioblastoma","volume":"114","author":"Duan","year":"2025","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.wneu.2026.125172_bib96","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1006\/gyno.2002.6647","article-title":"A phase II trial of daily perillyl alcohol in patients with advanced ovarian cancer: Eastern Cooperative Oncology Group Study E2E96","volume":"85","author":"Bailey","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.wneu.2026.125172_bib97","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1023\/A:1025437115182","article-title":"Phase II trial of perillyl alcohol (NSC 641066) administered daily in patients with metastatic androgen independent prostate cancer","volume":"21","author":"Liu","year":"2003","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.wneu.2026.125172_bib98","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00280-007-0585-6","article-title":"Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer","volume":"62","author":"Bailey","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.wneu.2026.125172_bib99","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jss.2008.02.005","article-title":"A pilot study of perillyl alcohol in pancreatic cancer","volume":"147","author":"Matos","year":"2008","journal-title":"J Surg Res"},{"key":"10.1016\/j.wneu.2026.125172_bib100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1385\/IJGC:32:2-3:125","article-title":"Phase II trial of perillyl alcohol in patients with metastatic colorectal cancer","volume":"32","author":"Meadows","year":"2002","journal-title":"Int J Gastrointest Cancer"},{"key":"10.1016\/j.wneu.2026.125172_bib101","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.surneu.2007.07.040","article-title":"Preliminary results from a phase I\/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas","volume":"70","author":"da Fonseca","year":"2008","journal-title":"Surg Neurol"},{"key":"10.1016\/j.wneu.2026.125172_bib102","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/17425247.2025.2464714","article-title":"Bringing intranasal drug delivery for malignancies in the brain to market","volume":"22","author":"Chen","year":"2025","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.wneu.2026.125172_bib103","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411722","article-title":"Paclitaxel delivery to the brain for glioblastoma treatment","volume":"24","author":"AbdEl-Haq","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.wneu.2026.125172_bib104","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/pharmaceutics15010059","article-title":"Tyrosine kinase inhibitors for glioblastoma multiforme: challenges and opportunities for drug delivery","volume":"15","author":"Brar","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.wneu.2026.125172_bib105","article-title":"Delivery of extracellular vesicles loaded with immune checkpoint inhibitors for immunotherapeutic management of glioma","volume":"28","author":"Lin","year":"2024","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.wneu.2026.125172_bib106","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2019.07.033","article-title":"Enhanced anti-angiogenic effects of bevacizumab in glioblastoma treatment upon intranasal administration in polymeric nanoparticles","volume":"309","author":"Sousa","year":"2019","journal-title":"J Control Release"},{"key":"10.1016\/j.wneu.2026.125172_bib107","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202420630","article-title":"Intranasal and intravenous sequential administration of survivin Peptide-CpG nanovaccines elicits potent immunity toward glioblastoma","volume":"37","author":"Shi","year":"2025","journal-title":"Mater Adv"},{"key":"10.1016\/j.wneu.2026.125172_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177958","article-title":"Nasal nanotherapeutics for central nervous system disorders: bridging the translational gap in central nervous system drug delivery","volume":"1003","author":"Zhang","year":"2025","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.wneu.2026.125172_bib109","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/nsr\/nwaa161","article-title":"Lipid-oligonucleotide conjugates for bioapplications","volume":"7","author":"Li","year":"2020","journal-title":"Natl Sci Rev"},{"key":"10.1016\/j.wneu.2026.125172_bib110","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/pharmaceutics17060775","article-title":"Intranasal drug delivery technology in the treatment of central nervous system diseases: challenges, advances, and future research directions","volume":"17","author":"Wu","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.wneu.2026.125172_bib111","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jconrel.2017.09.001","article-title":"Progress in brain targeting drug delivery system by nasal route","volume":"268","author":"Khan","year":"2017","journal-title":"J Control Release"},{"key":"10.1016\/j.wneu.2026.125172_bib112","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/jphp.13316","article-title":"Nose-to-brain delivery of sumatriptan-loaded nanostructured lipid carriers: preparation, optimization, characterization and pharmacokinetic evaluation","volume":"72","author":"Masjedi","year":"2020","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.wneu.2026.125172_bib113","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/03639045.2019.1576724","article-title":"Nanostructured lipid carriers engineered for intranasal delivery of teriflunomide in multiple sclerosis: optimization and in vivo studies","volume":"45","author":"Gadhave","year":"2019","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.wneu.2026.125172_bib114","first-page":"31","article-title":"Ziprasidone hydrochloride loaded nanostructured lipid carriers (NLCs) for intranasal delivery: optimization and in vivo studies","volume":"11","author":"Sivadasu","year":"2020","journal-title":"Int J Appl Biol Pharm"},{"key":"10.1016\/j.wneu.2026.125172_bib115","doi-asserted-by":"crossref","first-page":"12343","DOI":"10.2147\/IJN.S497480","article-title":"Nose to brain: exploring the progress of intranasal delivery of solid lipid nanoparticles and nanostructured lipid carriers","volume":"19","author":"Zheng","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.wneu.2026.125172_bib116","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202401213","article-title":"Effect of polymer and cell membrane coatings on theranostic applications of nanoparticles: a review","volume":"13","author":"Rezaei","year":"2024","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.wneu.2026.125172_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105892","article-title":"Revisiting inorganic nanoparticles as promising therapeutic agents: a paradigm shift in oncological theranostics","volume":"164","author":"Khan","year":"2021","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.wneu.2026.125172_bib118","first-page":"4919","article-title":"Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches","volume":"10","author":"Velasco-Aguirre","year":"2015","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.wneu.2026.125172_bib119","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.4103\/1673-5374.385875","article-title":"Intranasal administration of stem cell-derived exosomes for central nervous system diseases","volume":"19","author":"Gotoh","year":"2024","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.wneu.2026.125172_bib120","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3390\/biomedicines10050985","article-title":"Intranasal administration of a TRAIL neutralizing monoclonal antibody adsorbed in PLGA nanoparticles and NLC nanosystems: an in vivo study on a mouse model of Alzheimer's disease","volume":"10","author":"Musumeci","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.wneu.2026.125172_bib121","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1039\/D1NR05460K","article-title":"Non-invasive transferrin targeted nanovesicles sensitize resistant glioblastoma multiforme tumors and improve survival in orthotopic mouse models","volume":"14","author":"Sandbhor","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.wneu.2026.125172_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121658","article-title":"Particulate levodopa nose-to-brain delivery targets dopamine to the brain with no plasma exposure","volume":"618","author":"Dimiou","year":"2022","journal-title":"Int J Pharm"},{"key":"10.1016\/j.wneu.2026.125172_bib123","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2147\/IJN.S397650","article-title":"In vitro evaluation of paliperidone palmitate loaded cubosomes effective for nasal-to-brain delivery","volume":"18","author":"Deruyver","year":"2023","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.wneu.2026.125172_bib124","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3390\/pharmaceutics16060746","article-title":"Chitosan nanoparticles for intranasal drug delivery","volume":"16","author":"Omidian","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.wneu.2026.125172_bib125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40035-025-00481-w","article-title":"Nose-to-brain drug delivery: from bench to bedside","volume":"14","author":"Drath","year":"2025","journal-title":"Transl Neurodegener"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875026003888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875026003888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:38:59Z","timestamp":1794548339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875026003888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":125,"alternative-id":["S1878875026003888"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2026.125172","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global Trends and Evolving Frontiers in Intranasal Delivery for CNS Diseases (2000\u20132025): A Bibliometric Analysis and Systematic Review","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2026.125172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"125172"}}